Editas Medicine, Inc. (EDIT)

Editas Medicine Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	548	201	105	828	611	1,817
Market Cap Growth	325.03%	90.94%	-87.31%	35.64%	-66.39%	-58.58%
Enterprise Value	441.51	119.66	-92.03	529.56	299.27	1,333
Last Close Price	3.57	2.05	1.27	10.13	8.87	26.55
PS Ratio	14.16	4.95	3.25	10.60	30.98	71.13
PB Ratio	79.29	7.35	0.78	2.37	1.69	3.28
P/TBV Ratio	74.84	6.67	0.78	2.20	1.69	3.24
EV/Sales Ratio	11.41	2.95	-2.85	6.78	15.18	52.19
EV/EBITDA Ratio	-	-	0.38	-	-	-
EV/EBIT Ratio	-	-	0.37	-	-	-
EV/FCF Ratio	-	-	0.42	-	-	-
Debt / Equity Ratio	13.11	2.41	0.54	0.07	0.09	0.03
Net Debt / Equity Ratio	-11.72	-2.56	-1.32	-0.82	-0.83	-0.85
Net Debt / EBITDA Ratio	0.49	0.45	0.72	1.76	1.37	2.52
Net Debt / FCF Ratio	0.37	0.42	0.81	2.09	1.66	2.76
Asset Turnover	0.23	0.15	0.08	0.15	0.03	0.04
Quick Ratio	3.17	3.50	3.71	5.27	5.81	10.67
Current Ratio	3.22	3.54	3.75	5.39	5.94	10.82
Return on Equity (ROE)	-687.49%	-198.14%	-98.10%	-43.17%	-48.22%	-40.65%
Return on Assets (ROA)	-64.82%	-60.60%	-59.75%	-33.39%	-37.92%	-30.90%
Return on Invested Capital (ROIC)	-4550.59%	-1280.18%	-327.16%	-128.92%	-160.45%	-132.09%
Return on Capital Employed (ROCE)	-87.13%	-79.09%	-71.73%	-38.01%	-41.66%	-33.74%
Buyback Yield / Dilution	-11.90%	-7.78%	-8.39%	-10.63%	-1.55%	-15.37%
Total Shareholder Return	-11.90%	-7.78%	-8.39%	-10.63%	-1.55%	-15.37%

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q